Explore more publications!

Reunion Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Health News.

Press releases published on February 17, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Onspire Health Marketing Releases New Report: 2026 Marketing Trends for Medical Practices
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
SI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026
Precision Optics Reports Second Quarter Fiscal Year 2026 Financial Results
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
PetVivo Reports Results for Third Quarter and First Nine Months of Fiscal 2026 
Voting Rights and Shares Capital of the Company
Information mensuelle relative au nombre total de droits de vote  et d’actions composant le capital social
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
Beta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Kyntra Bio to Participate in Upcoming Investor Conferences
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
Portsmouth Square, Inc. Reports Second Quarter Fiscal 2026 Results; Hotel Performance Improves Year-Over-Year as Market Stabilization Continues
HealthEquity Delivers Record Q4 and Standout Fiscal 2026 Sales Metrics
Fortrea erweitert Führungsteam und ernennt Oren Cohen zum Chief Medical Officer und Scott Dove zum President of Clinical Pharmacology Services

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions